KEYLIGHTS BIOLOGICAL TECHNOLOGY(CHONGQING)CO.,LTD.

keylights (Shenzhen) Technology Co., Ltd. (hereinafter referred to as "keylights(Shenzhen)") and its subsidiaries have always focused on the research and development, production, and sales of in vitro diagnostic equipment, and are leading medical equipment technology innovation enterprises in China. The company is headquartered in the Venture Capital Building of Nanshan Science and Technology Park in Shenzhen, with two research and development centers, keylights (Shenzhen) and keylights (Chongqing), focusing on the research and development of chemiluminescence and molecular diagnostic instruments. Its controlling subsidiary, Chongqing key-smile , focuses on the research and manufacturing of chemiluminescence and immunofluorescence instruments. After 9 years of development, the company has become a core partner of multiple listed and proposed companies. Its products have covered 1000 well-known tertiary hospitals and third-party medical testing institutions, and have been successfully installed and used in countries such as the United States, Germany, France, Spain, etc., gradually becoming an independent brand of in vitro diagnostic equipment and a global supplier of CDMO. The company has an open chemiluminescence analysis instrument platform with fully independent intellectual property rights. Based on the long-term accumulation of clinical application needs and the system integration advantages of professional automation control technology platforms, the company is dedicated to providing customized development of chemiluminescence instruments for diagnostic reagent manufacturers and scientific researchers, as well as commissioned research and development of other analytical instruments such as molecular diagnosis and immunofluorescence. The company has established a strong technical evaluation and medical device registration and application service team, and has established 5 offices nationwide, with a comprehensive after-sales service guarantee system. We will spare no effort to assist diagnostic reagent developers in